Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y007585 | — |
administered after temperature excursions; no adverse event; This spontaneous report was received from Other Health Professional and refers to a currently 22-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, lot #Y007585, expiration date: 31-OCT-2025, administered for prophylaxis (strength, dose, dose number, frequency, scheme, anatomical location, and route of administration were not provided) (Improper storage of product in use). The vaccine underwent a temperature excursion during 1h 30 m under 60 Fahrenheit Degrees. No previous temperature excursions. No adverse event reported. This case was previously reported as non-valid due to lack of individual patient identifiers, but upon follow-up information on 17-JAN-2025, was updated to valid. This case was one of three from the same reporter. ; Sender Comments: Keywords : MUL US-009507513-2502USA000139:Original Case : 2501USA004754 US-009507513-2501USA004754:Original Case : 2501USA004754